Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE: rhPro-UK for Acute Posterior Circulation Ischemic Stroke in the Extended Window
NCT07617870Phase 3Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human prourokinase in ischemic stroke, sponsored by The First Affiliated Hospital of Zhengzhou University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
recombinant human prourokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07617870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07617870.